Effects of the Switching From High-Purity Eicosapentaenoic Acid to Combination of Eicosapentaenoic Acid and Docosahexaenoic Acid on Metabolic Parameters: A Retrospective Longitudinal Study

Hisayuki Katsuyama, Shohei Matsuura, Hidekatsu Yanai

Abstract


Background: Effects of the switching from high-purity eicosapentaenoic acid ester (hp-EPA) to n-3 fatty acid formulation containing EPA and docosahexaenoic acid (DHA) on metabolic parameters remain largely unknown.

Methods: We retrospectively picked up patients who had been prescribed EPA + DHA for 2 months or longer after the prescription of hp-EPA for 2 months or longer between January 2010 and December 2015. We compared the data at baseline and at 2 months after the switching from hp-EPA to EPA + DHA.

Results: Thirty-six patients were eligible for the analyses in our study. Serum triglyceride (TG) showed a non-significant decrease by approximately 9% after the switching. Serum TG showed a non-significant decrease by 24% and 10%, in the switching to the formulation including half daily dose of EPA and DHA and the formulation including the same daily dose of EPA and DHA, respectively. In patients who had shown a decrease in TG after the switching, serum TG at baseline was higher than that in patients who had shown an increase and non-change in TG after the switching. Further, in patients who had shown a decrease in TG after the switching to the formulation including the same daily dose of EPA and DHA, serum TG was significantly higher than that in patients who had shown an increase and non-change in TG. In the analysis of all patients, in patients with baseline TG >= 150 mg/dL, TG tended to decrease. In the analysis of patients who underwent the switching to the formulation including the same daily dose of EPA and DHA, in patients with baseline TG >= 150 mg/dL, TG significantly decreased.

Conclusion: We studied effects of the switching from hp-EPA to EPA + DHA on metabolic parameters, and found that the switching is more effective to reduce TG in patients with higher TG levels at baseline.




J Endocrinol Metab. 2016;6(3):75-79
doi: http://dx.doi.org/10.14740/jem348w


Keywords


Coronary risk factors; Docosahexaenoic acid; Eicosapentaenoic acid; Triglyceride

Full Text: HTML PDF
 

Browse  Journals  

 

Journal of Clinical Medicine Research

Journal of Endocrinology and Metabolism

Journal of Clinical Gynecology and Obstetrics

 

World Journal of Oncology

Gastroenterology Research

Journal of Hematology

 

Journal of Medical Cases

Journal of Current Surgery

Clinical Infection and Immunity

 

Cardiology Research

World Journal of Nephrology and Urology

Cellular and Molecular Medicine Research

 

Journal of Neurology Research

International Journal of Clinical Pediatrics

 

 
       
 

Journal of Endocrinology and Metabolism, bimonthly, ISSN 1923-2861 (print), 1923-287X (online), published by Elmer Press Inc.                     
The content of this site is intended for health care professionals.
This is an open-access journal distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License, which permits unrestricted
non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
Creative Commons Attribution license (Attribution-NonCommercial 4.0 International CC-BY-NC 4.0)


This journal follows the International Committee of Medical Journal Editors (ICMJE) recommendations for manuscripts submitted to biomedical journals,
the Committee on Publication Ethics (COPE) guidelines, and the Principles of Transparency and Best Practice in Scholarly Publishing.

website: www.jofem.org   editorial contact: editor@jofem.org    elmer.editorial2@hotmail.com
Address: 9225 Leslie Street, Suite 201, Richmond Hill, Ontario, L4B 3H6, Canada

© Elmer Press Inc. All Rights Reserved.


Disclaimer: The views and opinions expressed in the published articles are those of the authors and do not necessarily reflect the views or opinions of the editors and Elmer Press Inc. This website is provided for medical research and informational purposes only and does not constitute any medical advice or professional services. The information provided in this journal should not be used for diagnosis and treatment, those seeking medical advice should always consult with a licensed physician.